Development and Characterization of Desmoglein-3 Specific T cells from Japanese Patients with Pemphigus Vulgaris
Development and Characterization of Desmoglein-3 Specific T cells from Japanese Patients with Pemphigus Vulgaris
批准号:
10670804
负责人:
SAKURAI Toshiharu
金额:
$2.43万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999
中文摘要
本研究的目的是调查日本患者对T淋巴细胞的反应,对白内障(PV)的反应,对Desmoglein 3、PV的自动抗原,并对Dsg 3-特定T细胞的特性进行表征。我们在14个日本PV患者中使用Amagai博士使用PCR-RFLP (聚合酶链反应-限制片段长度多态性)方法进行了高分辨率HLA II型。与健康个人相比,DRB 1*14 (14/14:100%)、DRB 1 *0503 (12/14:85%)或DRB 1 *0301(9/12:64%)都有重要的关联。2. 11种可重组Dsg 3融合蛋白(Dsg 3)1-11)与麦芽糖结合蛋白(MBP)准备好每个40个氨基酸被15个驻地标记,从Dsg 33的EC 1开始。对14名PV患者和20个健康控制的PBMC与11个重组Dsg 3融合蛋白和[YYYD 13 YD 1H]-胸腺嘧啶的克隆的自主T细胞反应。体外T细胞的初级反应(SI=1.9-2.7)对Dsg 3.9 (201-204)或Dsg 3.10 (226-265)有观察到的11/14 PV患者和7/14健康个人对与PV相关的HLA-DRB 1 *14和DQB 1 *05的观察。在相反的情况下,来自6种正常控制的PBMC携带HLA II类其他的DRB 1 *14和DQB 1 *05没有被重组Dsg 3融合蛋白刺激。这些观测表明,可以在PV患者中检测到Dsg 3的T细胞反应,并在健康的捐赠者携带主要的历史兼容性复合体类II警报中确定或类似于那些在PV中具有高度优先地位的人。并建议Dsg 3分子EC2-3区域可能包含由Dsg 3特定T细胞识别的表位。本研究将允许我们进一步发展和表征日本PV患者的Dsg 3特定T细胞克隆体。
英文摘要
The purpose of this study is to investigate the response of T lymphocytes from Japanese patients with pemphigus vulgaris (PV) to Desmoglein 3, the autoantigen of PV, and to characterize the properties of Dsg 3-specific T cells.1. We performed high resolution HLA class II typing in 14 Japanese PV patients presented from Dr Amagai using the PCR-RFLP (polymerase chain reaction-restriction fragment length polymorphism) method. There was a significant association of either DRB 1*14 (14/14:100%), DQB1*0503 (12/14:85%), or DQB1*0301(9/12:64%), when compared with healthy individuals. 2. The 11 recombinant Dsg 3 fusion proteins (Dsg 3. 1-11) with Maltose Binding Protein (MBP) were prepared to encompass each 40 amino acids staggered by 15 residues, starting from the EC 1 of Dsg 33. Autoreactive T cell responses to Dsg 3 were investigated in 14 PV patients and 20 healthy controls by coculture of PBMC with the 11 recombinant Dsg 3 fusion proteins and the incorporation of [ィイD13ィエD1H]-thymidine. Primary in vitro T cell responses (SI=1.9-2.7) to Dsg 3.9 (residues 201-204) or Dsg 3.10 (residues 226-265) were observed in 11/14 PV patients and 7/14 healthy individuals expressing the PV-associated HLA-DRB1*14 and DQB1*05. In contrast, PBMC from 6 normal controls carrying HLA class II alleles other than DRB1*14 and DQB1*05 were not stimulated by recombinant Dsg 3 fusion proteins. These observations demonstrate that T cell response to Dsg 3 can be detected in PV patients and in healthy donors carrying major histocompatibility complex class II alleles identical or similar to those highly prevalent in PV. And that suggests EC2-3 region of the Dsg 3 molecule may contain epitopes that are recognized by Dsg 3-specific T cell. This study will allow us to further develop and characterize the Dsg 3-specific T cell clone in Japanese PV patients.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Amagai Masayuki: "Autoimmunity against desmosomal cadherins in pemphigus"J Dermatol Sci.. 20. 92-102 (1999)
Amagai Masayuki:“天疱疮中针对桥粒钙粘蛋白的自身免疫”J Dermatol Sci.. 20. 92-102 (1999)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Amagai Masayuki: "Usefulness of enzyme-linked immunosorbent assay (ELISA) using reconbinant desmogleins 1 and 3 for serodiagnisis of pemphigus"British Journal of Dermatology. 140. 351-357 (1999)
Amagai Masayuki:“使用重组桥粒芯糖蛋白 1 和 3 进行酶联免疫吸附测定 (ELISA) 对天疱疮血清学诊断的有用性”《英国皮肤病学杂志》。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Amagai Masayuki: "The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile"J Am Acad Dermatol. 40. 167-170 (1999)
Amagai Masayuki:“天疱疮的临床表型是由抗桥粒芯糖蛋白自身抗体谱定义的”J Am Acad Dermatol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Amagai Masayuki: "Autoimmunology against desmosomal cadherins in pemphigus"Journal of Dermatological Science. 20. 92-102 (1999)
Amagai Masayuki:“针对天疱疮桥粒钙粘蛋白的自身免疫学”皮肤病学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Nishifuji koji: "Detection of antigen-specific B cells in patients with pemphigus vulgaris by enzyme-linked immunospot (ELISPOT) Assay: requirement of T cell collaboration for autoanlibody production."J Invest Dermatol. 114(1). 88-94 (2000)
Nishifuji koji:“通过酶联免疫斑点 (ELISPOT) 检测寻常型天疱疮患者的抗原特异性 B 细胞:自身抗体生产需要 T 细胞协作。”J Invest Dermatol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 11 条
Molecular link between stress response and cancer and its clinical implication
-
批准号:17K09396
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2017
-
负责人:SAKURAI Toshiharu
-
依托单位:
Novel molecular target in colorectal cancer and inflammatory bowel disease
-
批准号:26460979
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2014
-
负责人:SAKURAI Toshiharu
-
依托单位:
Translational research focusing on the regulation of proteasome by Gankyrin
-
批准号:23590998
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:SAKURAI Toshiharu
-
依托单位:
Elucidation of the resistance mechanisms of immunotherapy by the abnormal signal transduction in melanoma and development of methods to overcome it
-
批准号:21591445
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:SAKURAI Toshiharu
-
依托单位:
The study of immunosuppressive mechanisms induced by gastrointestinal cancer during epithelial-mesnchymal transition and clinical application of this target therapy
-
批准号:18591484
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.57万
-
财政年份:2006
-
负责人:SAKURAI Toshiharu
-
依托单位:
Identification of novel autoantigens using human IgG in SCID mice implanted with lacrimal and salivary grands from patients with Sjogren's Syndrome
-
批准号:16590324
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2004
-
负责人:SAKURAI Toshiharu
-
依托单位:
Using soluble HLA-peptide tetramer, the studies on the cloning and immune-response monitoring of melanoma antigen-specific cytotoxic lymphocyte
-
批准号:13670901
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:SAKURAI Toshiharu
-
依托单位:
Using solubel peptide-MHC tetramer, the trial of staining and cloning the melanoma antigen-specific cytotoxic lymphocytes
-
批准号:11670849
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.43万
-
财政年份:1999
-
负责人:SAKURAI Toshiharu
-
依托单位:
海外基金